Metformin use and clinical outcomes among patients with diabetes mellitus with or without heart failure or kidney dysfunction: observations from the SAVOR-TIMI 53 trial
The Five-Minute 503A Category Explainer Section 503A of the Federal Food, Drug, and Cosmetic Act lets state-licensed pharmacies compound drugs from bulk substances under specific conditions
AA received research grants and lecture or advisory board fees from MSD, AstraZeneca, Novartis, Boehringer Ingelheim, Sanofi, Mediolanum, Janssen, Novo Nordisk, Lilly, Servier and Takeda
Nutrients, 11(2), 395
Lipids as regulators of cellular senescence
Differentiating effects of somatomedin-C/insulin-like growth factor I and insulin on Leydig and Sertoli cell functions